Please assess the completion status of the following clinical trial:

Trial Title: Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* age ≥ 18 years~* polymerase chain reaction (PCR) confirmed COVID-19~* severe stage of pneumonia caused by SARS-CoV-2 requiring oxygen therapy~* informed consent to participate in the study~Exclusion Criteria:~* qualification to palliative care~* life expectancy \< 48 h~* mechanical ventilation at the beginning of the hospitalization~* transfer from other ICU~* pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).